1. Home
  2. NATL vs DYN Comparison

NATL vs DYN Comparison

Compare NATL & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$42.33

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$17.45

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
DYN
Founded
2023
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
NATL
DYN
Price
$42.33
$17.45
Analyst Decision
Hold
Strong Buy
Analyst Count
4
14
Target Price
$45.60
$37.00
AVG Volume (30 Days)
1.4M
2.2M
Earning Date
05-06-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
73.98
N/A
EPS
2.14
N/A
Revenue
$4,354,000,000.00
N/A
Revenue This Year
$6.13
N/A
Revenue Next Year
$4.24
N/A
P/E Ratio
$20.02
N/A
Revenue Growth
0.86
N/A
52 Week Low
$22.30
$7.01
52 Week High
$48.50
$25.00

Technical Indicators

Market Signals
Indicator
NATL
DYN
Relative Strength Index (RSI) 45.30 50.66
Support Level $37.97 $16.34
Resistance Level $43.43 $20.08
Average True Range (ATR) 1.10 1.18
MACD -0.52 0.14
Stochastic Oscillator 3.79 52.31

Price Performance

Historical Comparison
NATL
DYN

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: